Exact Mass: 747.6379658000001

Exact Mass Matches: 747.6379658000001

Found 500 metabolites which its exact mass value is equals to given mass value 747.6379658000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PC(O-16:0/18:0)

(2-{[(2R)-3-(hexadecyloxy)-2-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H86NO7P (747.6141576)

PC(O-16:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-16:0/18:0), in particular, consists of one chain of Palmityl alcohol at the C-1 position and one chain of stearic acid at the C-2 position. The Palmityl alcohol moiety is derived from animal fats and vegetable oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-16:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:0/18:0), in particular, consists of one chain of Palmityl alcohol at the C-1 position and one chain of stearic acid at the C-2 position. The Palmityl alcohol moiety is derived from animal fats and vegetable oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

Hydrogenated egg phosphatidylcholine

(2-{[3-(hexadecanoyloxy)-2-(octadecyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C42H86NO7P (747.6141576)

Tetrac

2-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid

C14H8I4O4 (747.6601648)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Tetrac (Tetraiodothyroacetic acid), a derivative of L-thyroxine (T4), is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T4 and 3,5,3'-triiodo-L-thyronine (T3) at the cell surface receptor for thyroid hormone on integrin αvβ3. Tetra has anti-angiogenic and anti-tumor activities[1][2].

Tetrac

C14H8I4O4 (747.6601648)

Phosphatidylcholine alkyl 18:0-16:0

C42H86NO7P (747.6141576)

PC(O-16:0/18:0)

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 7-[(hexadecyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (R)-

C42H86NO7P (747.6141576)

PC(O-16:0/18:0)[S]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 7-[(hexadecyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (S)-

C42H86NO7P (747.6141576)

PC(O-16:0/18:0)[U]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 7-[(hexadecyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C42H86NO7P (747.6141576)

PC(O-17:0/17:0)

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-[(1-oxoheptadecyl)oxy]-, inner salt, 4-oxide, (R)-

C42H86NO7P (747.6141576)

PC(O-18:0/16:0)

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide, (R)-

C42H86NO7P (747.6141576)

PC(O-18:0/16:0)[S]

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide, (S)-

C42H86NO7P (747.6141576)

PC(O-18:0/16:0)[U]

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide

C42H86NO7P (747.6141576)

PC(O-20:0/14:0)

1-eicosyl-2-tetradecanoyl-glycero-3-phosphocholine

C42H86NO7P (747.6141576)

PC(18:0/O-16:0)

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 7-(hexadecyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

C42H86NO7P (747.6141576)

PE(O-16:0/21:0)

1-hexadecyl-2-heneicosanoyl-glycero-3-phosphoethanolamine

C42H86NO7P (747.6141576)

PE(O-18:0/19:0)

1-octadecyl-2-nonadecanoyl-glycero-3-phosphoethanolamine

C42H86NO7P (747.6141576)

PE(O-20:0/17:0)

1-eicosyl-2-heptadecanoyl-glycero-3-phosphoethanolamine

C42H86NO7P (747.6141576)

PC O-34:0

1-heptadecyl-2-heptadecanoyl-sn-glycero-3-phosphocholine

C42H86NO7P (747.6141576)

PE O-37:0

1-hexadecyl-2-heneicosanoyl-glycero-3-phosphoethanolamine

C42H86NO7P (747.6141576)

Tetraterbium heptaoxide

O7Tb4 (747.6658050000001)

3-(Octadecyloxy)-2-(palmitoyloxy)propyl 2-(trimethylammonio)ethyl phosphate

C42H86NO7P (747.6141576)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(2-hydroxynonadecanoylamino)-15-methylhexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C41H84N2O7P+ (747.6015824000001)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-(nonadecanoylamino)octadecoxy]phosphoryl]oxyethyl-trimethylazanium